DrugXperts.com

09/11/2023

29/08/2017

Do you believe in corticosteroids all the time?

Then, Check this out
Effect of oral prednisolone on symptom duration in lower respiratory tract infection

.


http://jamanetwork.com/journals/jama/article-abstract/2649201?utm_source=FBPAGE&utm_medium=social_jn&utm_term=1034310926&utm_content=content_engagement%7carticle_engagement&utm_campaign=article_alert&linkId=41373876

This randomized trial compares the effect of prednisolone vs placebo on duration of moderately bad or worse cough and severity of symptoms in nonasthmatic adults with acute lower respiratory infections.

01/06/2017

AACE 2017 Guidelines

GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION
OF CARDIOVASCULAR DISEASE
Link for download :https://www.aace.com/files/lipid-guidelines.pdf

31/05/2017

Deprescribing proton pump inhibitors:

Proton pump inhibitors are often viewed as safe and well tolerated medications, and while the incidence of side effects, such as diarrhea,impaired B12 absorption, hypomagnesemia, Clostridium difficile infection, hip fractures, and pneumonia might be small, older people might be at higher risk of these conditions. When PPIs are inappropriately prescribed or used for too long, they can contribute to polypharmacy with its attendant risks of nonadherence, prescribing cascades, adverse reactions, medication errors, drug interactions, emergency department visits, and hospitalization
The target population includes adults older than 18 years of age (including the elderly) taking a continuous PPI for longer than 28 days for the purpose of treating GERD or esophagitis. The guideline does not apply to those with Barrett esophagus, those with severe esophagitis ,or those with documented history of bleeding gastrointestinal (GI) ulcers. Individual situations in which there might be risk factors that warrant continued use of PPIs are also outlined.



Reference :
http://www.cfp.ca/content/63/5/354.long

10/05/2017

This video illustrates the latest definitions of and clinical criteria for diagnosing sepsis and septic shock based on recommendations from JAMA expert task force.
Learn more at http://jamasepsis.com.

01/03/2017

Thiazide diuretics can contribute to each of the following
metabolic effects EXCEPT
A. Hypomagnesemia
B. Hypouricemia
C. Hypercalcemia
D. Hypertriglyceridemia
E. Hyponatremia

26/02/2017

Ticagrelor versus Clopidogrel in symptomatic PAD patients

Ticagrelor did not demonstrate a benefit over clopidogrel in symptomatic peripheral artery disease (PAD) patients, according to the results of the EUCLID Trial -
See more at: https://www.acc.org/latest-in-cardiology/articles/2016/11/10/15/11/sun-445pmet-euclid-effects-of-ticagrelor-vs-clopidogrel-in-pad-aha-2016 .o3CDSkKJ.dpuf
https://www.acc.org/latest-in-cardiology/articles/2016/11/10/15/11/sun-445pmet-euclid-effects-of-ticagrelor-vs-clopidogrel-in-pad-aha-2016

Ticagrelor did not demonstrate a benefit over clopidogrel in symptomatic peripheral artery disease (PAD) patients, according to the results of the

16/02/2017

2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

https://academic.oup.com/cid/article/2996079/2017-Infectious-Diseases-Society-of-America-s?searchresult=1

Allan R. Tunkel, Rodrigo Hasbun, Adarsh Bhimraj, Karin Byers, Sheldon L. Kaplan, W. Michael Scheld, Diederik van de Beek, Thomas P. Bleck, Hugh J.L. Garton, Joseph R. Zunt; 2017 Infectious Diseases Society of America’s Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningit...

15/02/2017

Which of the following statements about diuretics in heart
failure is true?
A. Mannitol is an effective diuretic in cardiac surgical
patients with decompensated heart failure
B. Aldosterone receptor antagonists lessen the tendency of
ACE inhibitors to cause hyperkalemia
C. Loop diuretics often result in hypokalemia and metabolic
acidosis
D. The effectiveness of loop diuretic agents is reduced by
nonsteroidal anti-inflammatory drugs

03/02/2017

Cost-Effectiveness of Histamine2 Receptor Antagonists Versus Proton Pump Inhibitors for Stress Ulcer Prophylaxis in Critically Ill Patients

.
.

To determine the cost‐effectiveness of stress ulcer prophylaxis with histamine2 receptor antagonists (H2RAs) versus proton pump inhibitors (PPIs) in critically ill and mechanically ventilated adults.A...

22/12/2016

The holidays don’t just bring joy, they also bring an increase in heart attacks. Know the warning signs of a heart attack before it’s too late. Act now to learn more. http://spr.ly/61858zsMN
.

The holidays don’t just bring joy, they also bring an increase in heart attacks. Know the warning signs of a heart attack before it’s too late. Act now to learn more. http://spr.ly/61858zsMN

28/09/2016

Aspirin

03/06/2016

Get ready for Ramadan by supporting and advising your patients :)




http://www.pharmaceutical-journal.com/learning/learning-article/how-pharmacists-can-support-and-advise-patients-during-ramadan/20201241.article

Pharmacists have an essential role in advising and counselling patients who are observing Ramadan. By understanding the possible compliance and adherence issues, pharmacists can support Muslim patients during this time.

19/05/2016

Drug Interactions that diabetic patients should avoid

http://www.pharmacytimes.com/resource-centers/diabetes/drug-interactions-diabetics-should-avoid?utm_source=Informz&utm_medium=Pharmacy%20Times&utm_campaign=PT_eNews_Daily_Humulin_5-18-16

Patients with diabetes have a higher pill burden than the general population, so pharmacists should pay particular attention to potential drug interactions with antidiabetic agents.

18/05/2016

Mitoxantrone may increase cancer risk in multiple sclerosis patients








http://www.specialtypharmacytimes.com/news/mitoxantrone-may-increase-cancer-risk-in-multiple-sclerosis-patients

Patients administered mitoxantrone for multiple sclerosis carry higher rates of breast and colorectal cancers and leukemia.

15/05/2016

FDA announces safety labelling changes for fluoroquinolones






http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm500325.htm

FDA announces safety labeling changes for fluoroquinolones Share Tweet Linkedin Pin it More sharing options Linkedin Pin it Email Print [5-12-16] Today, the FDA is requiring labeling changes for antibacterial drugs called fluoroquinolones, including an updated boxed warning, stating that the serious...